<DOC>
	<DOCNO>NCT00501683</DOCNO>
	<brief_summary>This study look relative amount GSK189075 find sample blood , urine , feces healthy male volunteer . Results study used understand drug convert body eliminate .</brief_summary>
	<brief_title>A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Are healthy , nonsmoking male . Are 30 55 year old , inclusive . Have Body Mass Index ( BMI ) 1930 kg/m2 , inclusive ; body weight &gt; 110 lb . Have history regular bowel movement ( least 4 time per week ) . Are willing able provide write informed consent start studyrelated procedure . Have significant laboratory abnormality history liver kidney disease . Have significant abnormality electrocardiogram ( ECG ) recording heart rhythm . Have current condition ( ) alters normal gastrointestinal ( GI ) function ( constipation removal gallbladder ) . Have illness require treatment physician 30 day screen fever illness 5 day dose . Have blood pressure outside normal range . Have rest pulse rate outside normal range . Have surgery within 3 month screen , unless approve GSK medical monitor . Have drug allergy investigator feel would make unsafe participate study . Have history current abuse alcohol . Have history current use illicit drug , positive drug screen . Have use tobacco product within 3 month prior screen positive cotinine test result . Are unable refrain food beverages contain coffee , tea , chocolate 72 hour dose study drug 24 hour dose . Have positive test human immunodeficiency virus ( HIV ) antibody hepatitis B surface antigen hepatitis C antibody . Have take prescription nonprescription drug , include vitamin , herbal product , plantderived supplement ( include St John 's Wort ) within 14 day ( less 5 halflives ) first dose study medication , unless approve GSK medical monitor Have participate investigational drug study within 30 day screen , participate within last 12 month study another radio label drug product . Have total radiation exposure previous 3year period 10 mSv ( either work participation research study ) . Clinical ( therapeutic diagnostic ) exposure include . Have donate blood ( 450 mL ) within previous 12 week . Are occupation require monitor radiation exposure , nuclear medicine procedure excessive xrays within past 12 month . Are able follow study direction .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>metabolite profiling</keyword>
	<keyword>excretion ,</keyword>
	<keyword>radioactivity ,</keyword>
	<keyword>pharmacokinetic ,</keyword>
	<keyword>mass balance ,</keyword>
</DOC>